Business Context and Reporting Period
Company: Alterity Therapeutics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: August 2019
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
Context: This filing incorporates by reference the company's Appendix 4E and Annual Report 2019 into Registration Statements on Form S-8 and Form F-3.
Key Financial Metrics
The provided filing text serves as a cover sheet and does not contain specific financial data. The following metrics are not present in the source text:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt
- Liquidity
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It references the inclusion of the Annual Report 2019, which would contain such comparative data, but the figures are not included in this excerpt.
Guidance, Outlook, and Risks
The provided text contains no management commentary, forward-looking guidance, risk factors, contingencies, or descriptions of unusual items. These details are expected to be found within the referenced Appendix 4E and Annual Report 2019.
Investor Verification Checklist
- Verify the full content of the referenced Appendix 4E and Annual Report 2019 for actual financial performance data.
- Confirm the status of the Registration Statements on Form S-8 (File No. 333-228671) and Form F-3 (Files No. 333-220886 and 333-231417) into which this report is incorporated.
- Review the Annual Report for details on the company's clinical pipeline and cash runway, as this filing does not disclose them.